产品介绍：
产品说明
包装
5, 25 mg in glass bottle
生化/生理作用
NSC43067 is a Cyclin-dependent kinase (Cdk) inhibitor which binds to a novel conserved site on Cdk, presumably the p27 binding pocket. The binding apparently directly induces Cdk1, Cdk2, and Cdk4 protein aggregation. Cdks 1, 2, 4, and 6 are the key Cdks that regulate the cell cycle, and are a target for a cancer treatment. NSC43067 arrests the cell cycle at the G0/G1 phase at lower concentrations and at the G2/M cell cycle phase at higher concentrations. The action appears to be reversible.
特点和优势
This compound is featured on the CDKs page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
基本信息
| 经验(实验)分子式 | C14H12OS |
| 分子量 | 228.31 |
| MDL编号 | MFCD00489751 |
| PubChem化学物质编号 | 329818472 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | light yellow to light tan |
| 溶解性 | DMSO: >20 mg/mL |
| 储存温度 | 2-8℃ |
| SMILES string | Cc1ccc(s1)C(=O)\C=C\c2ccccc2 |
| InChI | 1S/C14H12OS/c1-11-7-10-14(16-11)13(15)9-8-12-5-3-2-4-6-12/h2-10H,1H3/b9-8+ |
| InChI key | AOUMOFQEBZGSPD-CMDGGOBGSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 - H413 |
| 预防措施声明 | P264 - P270 - P273 - P301 + P312 - P501 |
| 危险分类 | Acute Tox. 4 Oral - Aquatic Chronic 4 |
| 储存分类代码 | 11 - Combustible Solids |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
